Cloud DX

About Cloud DX

Cloud DX (TSXV:CDX, OTCQB:CDXFF) operates as a virtual care and remote patient monitoring (RPM) provider for healthcare organizations across North America. The company was established in late 2014 by Robert Kaul, a seasoned entrepreneur with nearly three decades of experience in leading early-stage technology companies. Kaul's journey in the digital health space began with the founding of Cloud Diagnostics LLC in 2009, which was later sold to Biosign Technologies Inc. He subsequently led Biosign as CEO before acquiring its medical device assets to launch Cloud DX as a new entity. This background provided Cloud DX with technology and expertise that predates its official founding.

The company's core offering is the Connected Health™ platform, which serves clients such as hospitals, medical clinics, and entire government health systems. Its business model centers on generating recurring revenue through subscriptions to this platform. This involves providing patients with a Connected Health™ Kit, which includes medical-grade, Bluetooth-enabled devices like blood pressure cuffs, oximeters, and scales. These devices transmit patient data to a mobile app and a central clinical portal where healthcare providers can monitor patients remotely, communicate via secure messaging and video, and manage care plans. This service is applied across various use cases, including chronic disease management for conditions like COPD and hypertension, post-surgical recovery, and aging in place.

The platform is designed to improve patient outcomes, enhance care efficiency, and lower healthcare costs by reducing hospitalizations and readmissions. A key differentiator is that Cloud DX manufactures its own FDA-cleared and Health Canada-licensed medical devices, allowing it to control the entire user experience from the patient's home to the clinician's dashboard, resulting in high patient satisfaction rates. Financially, the company has demonstrated significant growth, reporting a 55.4% increase in total revenue for fiscal year 2023 compared to 2022, driven by a 69% rise in subscription revenue. Key milestones include becoming a publicly traded company on the TSX Venture Exchange in April 2021, and winning the Bold Epic Innovator Award from the Qualcomm Tricorder XPRIZE. The company has also established strategic partnerships with Medtronic Canada, Teladoc Health, and Sanrai International to expand its reach.